Fatigue in Anemia: Pathophysiology and Clinical Impact

Anemia (Hb <13 g/dL men, <12 g/dL women) reduces blood oxygen-carrying capacity, leading to tissue hypoxia and fatigue.

Mechanisms of Fatigue

  1. Reduced O₂ Delivery: ↓ Hb → ↓ arterial O₂ content (CaO₂ = Hb × 1.34 × SaO₂ + 0.003 × PaO₂). Cardiac output ↑ compensates partially but insufficient at exertion.
  2. Impaired Cellular Respiration: Mitochondrial O₂ shortage → ↓ ATP from oxidative phosphorylation → ↑ anaerobic glycolysis → lactate, early fatigue.
  3. Cardiac Strain: High-output state → tachycardia, increased stroke volume → long-term: eccentric hypertrophy, high-output heart failure.
  4. Cerebral Hypoxia: Brain consumes 20% O₂; sensitive to reduced delivery → cognitive fatigue, poor concentration.
  5. Iron Deficiency (even without anemia): Iron needed for mitochondrial enzymes (cytochromes), dopamine synthesis, myelin. Fatigue can precede anemia.
  6. Inflammation (Anemia of Chronic Disease): Hepcidin ↑ → iron sequestration; cytokines (IL-6, TNF-α) → sickness behavior (fatigue, anhedonia).
  7. Clinical Assessment

    • History: onset, progression, menstrual/blood loss, diet, medications, family history.
    • CBC + indices (MCV, MCH, RDW) → microcytic, normocytic, macrocytic.
    • Iron studies: ferritin (acute phase reactant), serum iron, TIBC, transferrin saturation.
    • Reticulocyte count (bone marrow response).
    • B12, folate, TSH, renal/liver function.

    Treatment → Fatigue Resolution

    • Iron deficiency: Oral/IV iron; Hb rises ~1 g/dL/week; fatigue improves before Hb normalizes.
    • B12/folate: Replacement.
    • Anemia of chronic disease: Treat underlying inflammation; ESA (erythropoiesis-stimulating agents) in select cases (CKD, chemo).
    • Transfusion: Acute severe symptomatic anemia (Hb <7–8 g/dL).

    Fatigue is multifactorial; correcting anemia is necessary but not always sufficient – address sleep, deconditioning, depression, medications.

Chronic Fatigue Syndrome - Related Articles